Evidence map›Paper›PMID 34436304›Full record

ArticleMarine drugs2021

Inhibition of A549 Lung Cancer Cell Migration and Invasion by

So Young Kim, Myoung-Sook Shin, Geum Jin Kim, Hyukbean Kwon, Myong Jin Lee, Ah-Reum Han, Joo-Won Nam, Chan-Hun Jung, Ki Sung Kang, Hyukjae Choi

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

So Young KimCollege of Pharmacy, Yeungnam University, Gyeongsan-si 38541, Gyeongsangbuk-do, Korea.
Myoung-Sook ShinCollege of Korean Medicine, Gachon University, Seongnam 13120, Gyeonggi-do, Korea.ORCID 0000-0002-5103-437X
Geum Jin KimCollege of Pharmacy, Yeungnam University, Gyeongsan-si 38541, Gyeongsangbuk-do, Korea.ORCID 0000-0001-8773-3853
Hyukbean KwonCollege of Pharmacy, Yeungnam University, Gyeongsan-si 38541, Gyeongsangbuk-do, Korea.
Myong Jin LeeCollege of Korean Medicine, Gachon University, Seongnam 13120, Gyeonggi-do, Korea.
Ah-Reum HanAdvanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup-si 56212, Jeollabuk-do, Korea.ORCID 0000-0001-7824-4441
Joo-Won NamCollege of Pharmacy, Yeungnam University, Gyeongsan-si 38541, Gyeongsangbuk-do, Korea.ORCID 0000-0001-5502-0736
Chan-Hun JungJeonju AgroBio-Materials Institute, Jeonju-si 54810, Jeollabuk-do, Korea.ORCID 0000-0003-3876-4201
Ki Sung KangCollege of Korean Medicine, Gachon University, Seongnam 13120, Gyeonggi-do, Korea.
Hyukjae ChoiCollege of Pharmacy, Yeungnam University, Gyeongsan-si 38541, Gyeongsangbuk-do, Korea.ORCID 0000-0002-7707-4767
Yeungnam University · KRGachon University · KRJeonnam Bioindustry Foundation · KRKorea Atomic Energy Research Institute · KR

Funding

Gachon University GCU-2019-0316Yeungnam University the 2020 Yeungnam University Research Grants
6 · The paper itself

Abstract

The epithelial-mesenchymal transition (EMT) of cancer cells is a crucial process in cancer cell metastasis. An

Indexed as

A549 CellsAnimalsAntineoplastic AgentsAquatic OrganismsCaproatesCell Line, TumorEpithelial-Mesenchymal TransitionFlavobacteriaceaeHumansLactonesTransforming Growth Factor betaAntineoplastic AgentsCaproatescaprolactoneLactonesTransforming Growth Factor betaA549 human lung cancer cellAquimarina sp.caprolactin Cent-caprolactin Cepithelial–mesenchymal transition

Identifiers

PMID34436304
PMCPMC8398538
OpenAlexW3194558493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.